Accession Number:

ADA574964

Title:

Development of Advanced Technologies for Complete Genomic and Proteomic Characterization of Quantized Human Tumor Cells

Descriptive Note:

Annual rept. 15 Jun 2011-14 Jun 2012

Corporate Author:

SWEDISH EPILEPSY CENTER SEATTLE WA

Personal Author(s):

Report Date:

2012-07-01

Pagination or Media Count:

5.0

Abstract:

Through this collaborative research effort, we intend to develop quantitative tools with direct applications for patients with glioblastoma. We will pursue new strategies for genome sequencing and new technologies for the genetic analyses of cancer mechanisms, as well as methods for assessment of progression and stratification of human glioblastoma. This proposal will significantly advance genomic, proteomic and single-cell technologies, and the proposed tools will be generally applicable to all cancer-based studies to identify and quantify DNA, RNAs, proteins and cells, challenges ubiquitous to all human disease systems.

Subject Categories:

  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE